Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Explore this article's sources with AI

ChatGPTClaudePerplexityGeminiGrokGoogle AI

Follow PeptideMethods on Google

First published

What Semax actually costs in the UK

Zero official UK Semax prices were found. MHRA and EMA checks identified no authorised pack to price, and vendor listings are excluded.

Why we wrote this. UK readers need a reproducible official-price absence finding that keeps national records, the EMA dataset, specials quotes and seller listings separate.

In this article (8 sections)
  1. What the UK product search showed
  2. The EMA workbook was checked separately
  3. Why there is no routine NHS figure
  4. A special would not create a national tariff
  5. Why seller prices are excluded
  6. Monthly cost estimates would add unsupported assumptions
  7. How to check a future UK price claim
  8. The current finding is price absence

We found zero official UK prices for Semax. The exact-phrase MHRA Products search returned no results for Semax on 8 November 2026[1]. A separate search of the current EMA medicines workbook found no match for Semax or the sequence names checked[2]. That means no authorised finished product, licensed pack or official national price was identified under those names.

Zero official UK prices found does not mean the price is zero. It means there is no regulator-identified Semax pack to which a UK list price, routine NHS reimbursement amount or standard patient charge can be attached. Online seller amounts are excluded because they do not establish an authorised medicine or a comparable finished product.

For background on the molecule and evidence, read the Semax overview. The UK regulation hub explains how authorisation and prescription status fit into the wider UK system. Neither page supplies a price for a product that the official searches did not identify.

What the UK product search showed

MHRA Products is the national product-information service. Its search page says that UK-authorised products carry identifiers such as PL, PLGB or PLNI numbers. An exact-phrase query for Semax returned the displayed message, 'There are no search results for "Semax"' on 8 November 2026[1]. Exact-phrase queries for MEHFPGP and Met-Glu-His-Phe-Pro-Gly-Pro returned the same no-result message.

The exact phrase matters because an unquoted Semax query is noisy. It returned hundreds of documents containing fragments such as Emax, Demax or other nearby character strings. Those are not Semax products. Counting fuzzy document hits as licensed Semax packs would turn a search-engine artefact into a regulatory claim.

Within the exact names checked, the national search supplied no product name, active substance, licence number, strength, dosage form, manufacturer or pack. That is the relevant boundary for pricing. An online page using the word Semax does not inherit a PL number or an official UK price merely because the name resembles the search term.

The EMA workbook was checked separately

EMA describes its downloadable table as data on approved medicines, withdrawn applications and opinion status, and says the tables update overnight[2]. We downloaded the current medicines workbook on 8 November 2026 and searched it separately for Semax, the Cyrillic form Семакс, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro and the space-separated sequence name. The workbook contained zero matches for those strings.

The EMA check is not a substitute for the MHRA search. EMA's workbook covers the central European dataset described on its page. MHRA Products is the national UK product-information search. The two checks answer related but separate questions, so this article does not present one as proof of the other.

A zero match is also narrower than a claim about every confidential or pending regulatory interaction. The workbook cannot reveal a private application that is not in the public dataset. It does show that the current public central table contains no medicine record under the searched Semax names. Combined with the national exact searches, it leaves no official pack from which to quote a UK price.

Why there is no routine NHS figure

Regulation 46 of the Human Medicines Regulations 2012 states that a person may not sell, supply, or offer to sell or supply an unauthorised medicinal product unless an applicable exception operates[3]. The official searches identified no authorised Semax finished product under the names checked. There is therefore no licensed Semax pack entering ordinary UK prescribing and dispensing with a public pack price attached.

NHS prescription charges and medicine acquisition costs are different figures, but neither supplies a Semax price here. Applying a general prescription charge to Semax would imply that a routine prescription item exists. No such item was found. Copying reimbursement criteria from another medicine would invent an NHS route that the Semax records do not establish.

The same limit applies to statements about free prescriptions in the devolved nations or exemptions in England. Those rules concern valid NHS prescription items and eligible patients. They cannot create a Semax product, pack or reimbursement decision. This article therefore gives no invented NHS patient price and no eligibility checklist.

A special would not create a national tariff

MHRA guidance defines specials as unlicensed products manufactured or imported for an individual patient after an order from an authorised prescriber[4]. The agency's import guidance says a business must notify MHRA before importing an unlicensed medicine and may proceed only if MHRA does not object[5]. These sources describe a controlled, patient-specific route. They do not say Semax is available through it.

A genuine specials proposal would have to identify the patient, prescriber, exact finished product and regulated participants in the supply chain. The official pages do not provide a Semax specials tariff or a standing catalogue price. The existence of the legal framework cannot be converted into proof that a pharmacy can source Semax for a particular patient.

If a regulated pharmacy produced a quote, the amount could include the source product, transport, import work, dispensing and professional services. It would apply to that proposed supply. It would not become the UK price for Semax, and it would not prove a national reimbursement policy. No such quote is used here.

Why seller prices are excluded

Websites advertise nasal sprays, powders and vials under the Semax name. Their checkout amounts may show what a seller asks, but they do not establish a regulator-verified product. A listing does not prove the claimed peptide identity, concentration, manufacture, storage history or connection to any authorised finished medicine.

The products are also not necessarily comparable with one another. A spray sold at one stated concentration and a vial sold by mass cannot be treated as two quotes for the same pack. Seller certificates may describe a submitted sample without proving chain of custody to the item delivered. Averaging those prices would produce a precise-looking number without a common product underneath it.

Vendor amounts are excluded rather than presented as a grey-market range. Publishing a range would age quickly, invite false comparisons and risk directing readers toward unverified supply. PeptideMethods does not sell Semax or arrange its sale, and a seller's willingness to ship to the UK is not evidence of authorisation, lawful supply or an official price.

Monthly cost estimates would add unsupported assumptions

A monthly estimate needs a defined product, amount used, frequency, wastage and duration. The official searches provided none of those inputs. Combining a vendor price with an assumed self-directed regimen would turn an unverified listing into dosing guidance. This article does not do that.

Clinic packages create a similar problem. A single total may combine consultation, testing, follow-up, delivery and a claimed product. Without the exact manufacturer, licence status, pharmacy and finished pack, the total cannot be compared with a national medicine price. A higher fee does not prove better product identity, and a lower fee does not prove value.

How to check a future UK price claim

Start with the exact product, not the seller's headline. Ask for the finished-product name, manufacturer, strength, dosage form, pack size and UK licence number. Search the exact product and active substance in MHRA Products. Check the current EMA workbook separately rather than assuming the national and central datasets are interchangeable.

For an NHS claim, require the named NHS or NICE record and make sure it refers to the same licensed pack. For a special, ask which prescriber, licensed importer and dispensing pharmacy are involved, then treat the quote as patient-specific. A product record, a reimbursement decision and a pharmacy charge are separate documents.

The current finding is price absence

As of 8 November 2026, the exact MHRA searches and the current EMA medicines workbook produced no Semax product match under the names checked. We therefore found zero official UK prices. That finding should be updated if an identifiable authorised pack, public reimbursement record or documented patient-specific route appears. Until then, vendor listings cannot fill the official record gap.

Medical disclaimer: This article is for educational and journalistic purposes only and does not constitute medical advice. Peptides discussed may be classified as prescription medicines or research chemicals depending on your jurisdiction. Always consult a qualified healthcare professional before using any peptide product. PeptideMethods.com does not sell, distribute, or facilitate the sale of any peptide product.

Regulatory disclaimer: This page reflects our understanding of the UK regulatory status and official price records as of 8 November 2026. Regulations and records change. Verify with the MHRA, the relevant NHS body and a registered pharmacy before making any decision. PeptideMethods.com is not a law firm and does not provide legal advice.

Frequently asked

How much does Semax cost in the UK?

Zero official UK prices were found on 8 November 2026. That means no authorised pack or national price was identified under the names checked, not that Semax costs zero pounds.

Is there an NHS price for Semax?

No routine NHS Semax price was identified because the official searches found no authorised finished product or licensed pack to prescribe, reimburse or charge for.

Could Semax be supplied as a special?

The specials framework covers patient-specific unlicensed medicines ordered by an authorised prescriber, but the sources reviewed do not establish that Semax is available through that route. Any genuine quote would be case-specific, not a national tariff.

Why are online Semax prices excluded?

Vendor listings do not prove an authorised or comparable finished medicine. They may differ in form, claimed concentration, manufacture and supply chain, so averaging them would not produce an official UK price.

Can a seller price be converted into a monthly Semax cost?

Not responsibly. A monthly figure would require an assumed product, amount, frequency and duration. Combining those assumptions with an unverified listing would create unsupported dosing guidance.

Sources

  1. [1]MHRA Products: exact-phrase Semax search returned no results on 8 November 2026Tier 1 · primary↩
  2. [2]European Medicines Agency: downloadable medicines dataTier 1 · primary↩
  3. [3]The Human Medicines Regulations 2012, regulation 46Tier 1 · primary↩
  4. [4]MHRA: Supply unlicensed medicinal products (specials)Tier 1 · primary↩
  5. [5]MHRA: Import a human medicineTier 1 · primary↩

No revisions yet. First published .

About the editorial team

PeptideMethods is written and edited by the PeptideMethods Editorial Team and published by Digital Compass Group Ltd. The team is not made up of medical professionals; every health, regulatory or dosage claim on the site is tied to a primary source and is not a substitute for advice from a qualified clinician.

See our editorial policy and methodology for how we research, source and verify.

Read the pillars